Longeveron (LGVN) Operating Expenses (2020 - 2026)

Longeveron (LGVN) recorded quarterly Operating Expenses of $5.0 million in Q1 2026, down 10.91% quarter-over-quarter from $5.7 million in Q4 2025, and down 7.64% on a YoY basis from $5.5 million in Q1 2025.

Longeveron (LGVN) Operating Expenses (2020 - 2026) Analysis & Trends

Longeveron's Operating Expenses history runs 7 years deep, the most recent figure standing at $5.0 million for Q1 2026.

  • In Q1 2026, Operating Expenses fell 7.64% year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $23.7 million (up 21.76% YoY), while the FY2025 annual figure was $24.1 million, up 30.88% from the prior year.
  • Operating Expenses was $5.0 million for Q1 2026 at Longeveron, down from $5.7 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $7.4 million in Q3 2025 to a low of $3.6 million in Q1 2022.
  • Historically, Operating Expenses has averaged $5.1 million across 5 years, with a median of $5.2 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Operating Expenses slumped 33.78% in 2024, then jumped 44.2% in 2025.
  • A 5-year view of Operating Expenses shows it stood at $5.2 million in 2022, then advanced by 4.86% to $5.4 million in 2023, then fell by 11.53% to $4.8 million in 2024, then gained by 17.56% to $5.7 million in 2025, then retreated by 10.91% to $5.0 million in 2026.
  • The last three Operating Expenses figures came in at $5.0 million (Q1 2026), $5.7 million (Q4 2025), and $7.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 4.33 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 32.68 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -138.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.82 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 15.76 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 574,669.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.85 Bn
9 Abivax 91.96 Bn 91.96 Bn - -67.40 Mn
10 Longeveron 20.35 Bn 20.33 Bn 264,000.00 5.04 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.04 Mn
Dec 31, 2025 5.66 Mn
Sep 30, 2025 7.44 Mn
Jun 30, 2025 5.54 Mn
Mar 31, 2025 5.46 Mn
Dec 31, 2024 4.81 Mn
Sep 30, 2024 5.33 Mn
Jun 30, 2024 3.84 Mn
Mar 31, 2024 4.42 Mn
Dec 31, 2023 5.44 Mn
Sep 30, 2023 5.22 Mn
Jun 30, 2023 5.81 Mn
Mar 31, 2023 4.79 Mn
Dec 31, 2022 5.19 Mn
Sep 30, 2022 5.28 Mn
Jun 30, 2022 4.38 Mn
Mar 31, 2022 3.56 Mn
Dec 31, 2021 4.10 Mn
Sep 30, 2021 5.07 Mn
Jun 30, 2021 5.27 Mn